Plasma cell-free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
Clin Transl Med
.
2026 Jan;16(1):e70573.
doi: 10.1002/ctm2.70573.
Authors
Jacob E Till
1
,
Ofer Gal-Rosenberg
2
,
Sophia G Giliberto
1
,
Nicholas J Seewald
3
,
Dominique G Ballinger
1
,
Heather E Samberg
1
,
Melinda R Yin
1
,
Qiao-Li Wang
4
,
Samuele Cannas
1
,
Kristine N Kim
5
,
Kyle Tien
1
,
Mohammed Sawi
1
,
Vidya Madineedi
4
,
C Sloane Furniss
4
,
Vasilena Gocheva
4
,
Jonathan Nowak
6
,
Lauren K Brais
4
,
Chen Yuan
4
,
Michael H Rosenthal
7
,
Robert Roses
8
,
Ronald DeMatteo
8
,
Major Kenneth Lee
8
,
Charles Vollmer
8
,
Hersh Sagreiya
9
,
Mark H O'Hara
1
,
Ruth Shemer
2
,
Brian Wolpin
4
,
Yuval Dor
2
,
Erica L Carpenter
1
Affiliations
1
Department of Medicine, Division of Haematology-Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
2
Department of Developmental Biology and Cancer Research, Hebrew University Institute for Medical Research, Israel-Canada, Jerusalem, Israel.
3
Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
4
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
5
Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
6
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
7
Department of Radiology, Harvard Medical School, Boston, Massachusetts, USA.
8
Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
9
Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
PMID:
41549760
PMCID:
PMC12813551
DOI:
10.1002/ctm2.70573
No abstract available